相关实验视频

Updated: Sep 11, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

多发性骨髓瘤及其前体疾病的危险因素

Wanyun Ma¹, Liang Zhao², Wen Zhou³

¹Cancer Research Institute, Xiangya School of Basic Medical Sciences, Central South University, Changsha 410008. wwyiiijh@csu.edu.cn.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

|August 11, 2025

概括

多发性骨髓瘤 (MM) 的危险因素包括遗传变化和可改变的因素,如肥胖和环境暴露. 针对这些因素的早期干预可以改善患者的治疗结果.

科学领域:

血液学血液学血液学
在瘤学瘤学.
遗传学遗传学是一个

背景情况:

多发性骨髓瘤 (MM) 是一种从前体状况 (如意义不明的单克隆性骨髓瘤病变 (MGUS) 和燃烧的多发性骨髓瘤 (SMM)) 发展起来的血液性恶性瘤.
了解MM病因对于早期检测和干预至关重要.
MM的发展是多因素的,受种族,遗传,年龄,肥胖和环境因素的影响.

研究的目的:

确定多发性骨髓瘤 (MM) 发病和进展的关键风险因素.
突出细胞遗传异常和可修改因素在MM中的作用.
为基于风险的查和早期干预策略提供信息.

主要方法:

在MM发育中对初级和二级细胞遗传异常的审查.
分析可修改的风险因素,包括肥胖,维生素D,除草剂暴露和肠道微生物群.
探索参与MM病变发生的分子途径 (例如,ACSS2-IRF4,SLC12A2-NEK2).

主要成果:

主要的细胞遗传异常 (例如,超化,t(11;14) 在MGUS阶段存在,而次要的异常 (例如,1q+,del(17p)) 驱动进展.
肥胖,维生素D缺乏,除草剂暴露和肠道失调与MM风险增加和进展有关.
特定的分子通路介导可修改因素对MM的影响.

结论:

细胞遗传异常和可修改因素在MM病变发生过程中至关重要.
针对细胞遗传异常 (例如,Bcl-2抑制剂) 和可修改因素 (例如,维生素D,微生物群调节) 提供治疗潜力.
基于风险的查和早期干预可以延迟MM的进展并改善预后.

关键词:

病因病因学病因学没有确定的意义的单克隆性胃病变.多发性骨髓瘤是多发性骨髓瘤的一种.有关风险因素的风险因素.燃烧着的多发性骨髓瘤

更多相关视频

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

相关概念视频

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...